Improved reliability of lymphoma diagnostics via PCR-based clonality testing: F Report of the BIOMED-2 Concerted Action BHM4-CT98-3936

Department of Pathology, UMC St Radboud, Nijmegen, The Netherlands; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands; Laboratoire d’Hematologie, Hôpital Necker-Enfants Malades, Paris, France; II Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany; Department of Immunology, Southampton General Hospital, Southampton, UK; Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain; Department of Molecular Haematology, University of Leeds, Leeds, UK; Department of Haematology, Instituto Portugués de Oncologia, Lisbon, Portugal; Department of Pathology, Hotel-Dieu de Paris, Paris, France; Department of Pathology, Instituto Portugués de Oncologia, Lisbon, Portugal; Department of Pathology, CHU Henri Mondor, Creteil, France; Department of Pathology, University of Wales College of Medicine, Cardif, UK; Molecular Pathology Program, CNIO, Madrid, Spain; Department of Pathology, Luitpoldkrankenhaus, Würzburg, Germany; Department of Pathology, Johann Wolfgang Goethe University Hospital, Frankfurt, Germany; Department of Pathology, Centre Hospitalier Lyon-Sud, PierreBenite, France; Institut für Pathologie, Charité – Universitätsmedizin Berlin, Berlin, Germany; Department of Haematology, Hopital Pitié-Salpétière, Paris, France; Wessex Immunology Service, Molecular Pathology Unit, Southampton University Hospitals, Southampton, UK; Department of Pathology, University Medical Center Groningen, Groningen, The Netherlands; Department of Haematology, Centre Hospitalier Lyon-Sud, Lyon, France and Department of Molecular Biology, Instituto Português de Oncologia, Lisbon, Portugal